Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is a biologically aggressive and diagnostically complex leukemia subtype—especially prevalent in pediatric and therapy-related ...

A new cancer treatment discovered by the University of California, San Diego Sanford Stem Cell Institute (SSCI) and developed ...

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...

Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of immature myeloid cells. Current treatments often fail to achieve durable remission, underscoring the ...